SO
ACOR

STRS Ohio’s Acorda Therapeutics ACOR Stock Holding History

STRS Ohio’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,846
Closed -$430K – 2285
2020
Q1 		$430K Buy
3,846
+1,084
+39% +$213K ﹤0.01% 1243
2019
Q4 		$676K Buy
2,762
+1,451
+111% +$366K ﹤0.01% 1216
2019
Q3 		$451K Buy
1,311
+598
+84% +$325K ﹤0.01% 1336
2019
Q2 		$655K Buy
713
+289
+68% +$355K ﹤0.01% 1077
2019
Q1 		$676K Buy
424
+73
+21% +$132K ﹤0.01% 1032
2018
Q4 		$655K Sell
351
-12
-3% -$26.1K ﹤0.01% 1000
2018
Q3 		$856K Buy
363
+75
+26% +$232K ﹤0.01% 969
2018
Q2 		$990K Sell
288
-17
-6% -$52.1K ﹤0.01% 896
2018
Q1 		$865K Sell
305
-39
-11% -$117K ﹤0.01% 943
2017
Q4 		$885K Buy
344
+35
+11% +$99.5K ﹤0.01% 923
2017
Q3 		$877K Sell
309
-45
-13% -$119K ﹤0.01% 947
2017
Q2 		$837K Buy
354
+71
+25% +$141K ﹤0.01% 923
2017
Q1 		$711K Sell
283
-1,080
-79% -$3.11M ﹤0.01% 1075
2016
Q4 		$3.08M Hold
1,363
– – 0.01% 590
2016
Q3 		$3.42M Buy
1,363
+62
+5% +$185K 0.02% 570
2016
Q2 		$3.98M Buy
1,301
+307
+31% +$998K 0.02% 533
2016
Q1 		$3.15M Buy
994
+50
+5% +$208K 0.01% 566
2015
Q4 		$4.85M Sell
944
-419
-31% -$1.83M 0.02% 487
2015
Q3 		$4.34M Buy
1,363
+102
+8% +$396K 0.02% 522
2015
Q2 		$5.04M Buy
1,261
+162
+15% +$626K 0.02% 507
2015
Q1 		$4.39M Buy
1,099
+20
+2% +$91.6K 0.02% 540
2014
Q4 		$5.29M Sell
1,079
-173
-14% -$742K 0.02% 494
2014
Q3 		$5.09M Sell
1,252
-70
-5% -$263K 0.02% 496
2014
Q2 		$5.35M Buy
1,322
+1,068
+420% +$4.35M 0.02% 487
2014
Q1 		$1.16M Sell
254
-49
-16% -$198K 0.01% 673
2013
Q4 		$1.06M Sell
303
-18
-6% -$70.2K ﹤0.01% 720
2013
Q3 		$1.32M Hold
321
– – 0.01% 679
2013
Q2 		$1.27M Buy
+321
New +$1.32M 0.01% 710

Other funds holding ACOR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

STRS Ohio's ACOR Position: Q2 2020 in Review

STRS Ohio sold out of Acorda Therapeutics (ACOR) in Q2 2020, closing a stake of 3,846 shares — an estimated $430K sold.

STRS Ohio first reported a position in ACOR in Q2 2013 and held it in 28 quarters. The position peaked at $5.35M in Q2 2014. 79 funds tracked by Wall St. Rank hold ACOR as of Q2 2020.

  • STRS Ohio reported no remaining Acorda Therapeutics position as of Q2 2020 after selling out during the quarter.
  • STRS Ohio sold 3,846 Acorda Therapeutics shares in Q2 2020, an estimated $430K.
  • STRS Ohio first reported a position in Acorda Therapeutics in Q2 2013 and held it in 28 quarters.
  • STRS Ohio's Acorda Therapeutics position peaked at $5.35M in Q2 2014.
  • 79 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2020.

Based on STRS Ohio's 13F filing for Q2 2020, filed 23 Jul 2020.